JACC: CardioOncology Pulse - Clinical Risk Mitigation, Pathophysiology, and Genetics of Anthracycline-Associated Cardiomyopathy
Apr 23, 2024•13 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Aarti Asnani, MD discusses anthracyline-induced cardiomyopathy, including risk mitigation strategies, underlying pathogenesis, genetic variants associated with increased risk of this adverse event, and gaps in our understanding. Moderated by Sarah Waliany, MD, MS.
For the best experience, listen in Metacast app for iOS or Android